Syngene International P/B Ratio
SYNGENE • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
3.37
High Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
3.37
Current Price
₹393.10
Book Value/Share
₹117.30
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹4,727 Cr
Share Capital
₹403 Cr
Reserves & Surplus
₹4,324 Cr
Outstanding Shares
403,000,000
Book Value per Share
₹117.30
Valuation Signal
Signal
Overvalued
Historical Avg
7.47
Historical Range
5.55 - 8.79
Percentile
0.0%
Sector Context
Sector Average
-0.17
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Syngene International
- Stock appears overvalued with PB of 3.37, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 54.9% below historical average
- Trading at premium to sector average PB of -0.17
P/B Ratio Historical Trend for Syngene International
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Syngene International
Additional stock information and data for SYNGENE
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.55 | ₹117.3 | ₹651.00 | ₹4,727 | High |
| 2024 | 8.1 | ₹105.92 | ₹858.45 | ₹4,258 | High |
| 2023 | 7.77 | ₹90.22 | ₹701.45 | ₹3,618 | High |
| 2022 | 7.12 | ₹82.24 | ₹585.55 | ₹3,298 | High |
| 2021 | 8.79 | ₹70.53 | ₹619.90 | ₹2,821 | High |
Sector P/B Ratio Comparison
Comparing Syngene International with other companies in Healthcare sector
Sector Average
-0.17
Sector Median
0.64
Lowest P/B
-11.33
Highest P/B
1.05
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.33 | ₹4,026 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |